(Q43666300)

English

Efficacy and safety of olanzapine, an atypical antipsychotic, in patients with schizophrenia: results of an open-label multicenter study in Japan

scientific article published in August 2001

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

25 November 2017

Efficacy and safety of olanzapine, an atypical antipsychotic, in patients with schizophrenia: results of an open-label multicenter study in Japan (English)

1 reference

Europe PubMed Central

25 November 2017

1 reference

based on heuristic

inferred from title

author name string

J Ishigooka

1

1 reference

Europe PubMed Central

25 November 2017

M Murasaki

2

1 reference

Europe PubMed Central

25 November 2017

S Miura

3

1 reference

Europe PubMed Central

25 November 2017

Olanzapine Early-Phase II Study Group

4

1 reference

Europe PubMed Central

25 November 2017

language of work or name

1 reference

based on heuristic

inferred from title

publication date

1 August 2001

1 reference

Europe PubMed Central

25 November 2017

Psychiatry and Clinical Neurosciences

1 reference

Europe PubMed Central

25 November 2017

55

1 reference

Europe PubMed Central

25 November 2017

353-363

1 reference

Europe PubMed Central

25 November 2017

4

1 reference

Europe PubMed Central

25 November 2017

Olanzapine versus haloperidol in the treatment of schizophrenia and schizoaffective and schizophreniform disorders: results of an international collaborative trial

1 reference

https://api.crossref.org/works/10.1046%2FJ.1440-1819.2001.00875.X

21 January 2018

Using the proportional odds model to assess the relationship between a multi-item and a global item efficacy scale in a psychiatric clinical trial

1 reference

https://api.crossref.org/works/10.1046%2FJ.1440-1819.2001.00875.X

21 January 2018

Olanzapine increases in vivo dopamine and norepinephrine release in rat prefrontal cortex, nucleus accumbens and striatum.

1 reference

https://api.crossref.org/works/10.1046%2FJ.1440-1819.2001.00875.X

21 January 2018

Radioreceptor binding profile of the atypical antipsychotic olanzapine.

1 reference

https://api.crossref.org/works/10.1046%2FJ.1440-1819.2001.00875.X

21 January 2018

Antipsychotic agents antagonize non-competitive N-methyl-D-aspartate antagonist-induced behaviors

1 reference

https://api.crossref.org/works/10.1046%2FJ.1440-1819.2001.00875.X

21 January 2018

Olanzapine and fluperlapine mimic clozapine in preventing MK-801 neurotoxicity.

1 reference

https://api.crossref.org/works/10.1046%2FJ.1440-1819.2001.00875.X

21 January 2018

Antagonism of phencyclidine-induced deficits in prepulse inhibition by the putative atypical antipsychotic olanzapine

1 reference

https://api.crossref.org/works/10.1046%2FJ.1440-1819.2001.00875.X

21 January 2018

Identifiers

10.1046/J.1440-1819.2001.00875.X

1 reference

Europe PubMed Central

25 November 2017

1 reference

Europe PubMed Central

25 November 2017

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q43666300&oldid=2102391723"